Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Intangibles (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Intangibles for 15 consecutive years, with $138.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Intangibles rose 372.55% to $138.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $138.2 million, a 372.55% increase, with the full-year FY2024 number at $151.8 million, up 407.45% from a year prior.
  • Intangibles was $138.2 million for Q3 2025 at Usana Health Sciences, down from $142.7 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $151.8 million in Q4 2024 to a low of $28.6 million in Q2 2024.
  • A 5-year average of $53.5 million and a median of $30.5 million in 2021 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: fell 12.73% in 2023, then skyrocketed 407.45% in 2024.
  • Usana Health Sciences' Intangibles stood at $30.3 million in 2021, then increased by 6.99% to $32.4 million in 2022, then dropped by 7.75% to $29.9 million in 2023, then surged by 407.45% to $151.8 million in 2024, then fell by 9.0% to $138.2 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Intangibles are $138.2 million (Q3 2025), $142.7 million (Q2 2025), and $147.2 million (Q1 2025).